Literature DB >> 7790607

Alterations in circulating vasoactive substances in the critically ill--a comparison between survivors and non-survivors.

J Boldt1, T Menges, D Kuhn, C Diridis, G Hempelmann.   

Abstract

OBJECTIVE: Regulation of circulatory homeostasis is based on several factors including various circulating vasoactive substances. Whether these regulators differ between survivors and non-survivors was investigated in critically ill patients.
DESIGN: Prospective study.
SETTING: Clinical investigation on a surgical intensive care unit of an university hospital. PATIENTS: 60 consecutive patients suffering from trauma (n = 21) or postoperative complications (n = 39) were studied prospectively. The patients were divided into survivors (n = 27) and non-survivors (n = 33). Therapy was adjusted to the standards of modern intensive care management by physicians who were not involved in the study. MEASUREMENTS AND
RESULTS: Endothelin-1, atrial natriuretic peptide (ANP), vasopressin, renin, and catecholamine (epinephrine, norepinephrine) plasma levels were measured from arterial blood samples using radioimmunoassay (RIA) or high-pressure liquid chromatography (HPLC) technique on the day of admission to ICU and during the following 5 days. Various hemodynamic parameters were also monitored during that period. The non-survivors showed elevated pulmonary artery pressure (PAP: 34.1 +/- 5.4 mmHg) and pulmonary capillary wedge pressure (PCWP: 20.3 +/- 7.3 mmHg) already at the beginning of the study. Cardiac index (CI) did not differ among the groups, whereas right ventricular ejection fraction (RVEF) decreased in the non-survivors. PaO2/FIO2 decreased only in the non-survivors, whereas VO2 increased in the survivors (from 246 +/- 48 to 331 +/- 43 ml/min). Plasma levels of renin (from 206 +/- 40 to 595 +/- 81 pg/ml) and vasopressin (from 5.78 +/- 0.82 to 7.97 +/- 0.69 pg/ml) increased significantly in the non-survivors. Epinephrine and norepinephrine plasma concentrations were elevated in the non-survivors already at baseline and tremendously increased in these patients during the following days. ANP plasma levels significantly increased also only in the non-survivors (from 188 +/- 63 to 339 +/- 55 pg/ml) (p < 0.05). Endothelin-1 decreased in the survivors, whereas it significantly increased in the non-survivors (from 3.62 +/- 0.68 to 9.37 +/- 0.94 pg/ml) during the study period (p < 0.05). Analyses of co-variance revealed overall no significant correlation between circulating vasoactive substances and hemodynamics.
CONCLUSIONS: Systemic and regional regulators of the circulation were markedly changed by critical illness. In survivors, these regulators almost normalized within the study period of 5 days, whereas in non-survivors these alterations were even aggravated. It can only be speculated whether these regulator systems were influenced by activation of various mediator systems or whether they themselves influenced the negative outcome in the non-survivors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790607     DOI: 10.1007/bf01701475

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  36 in total

1.  Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis.

Authors:  J F Pittet; D R Morel; A Hemsen; K Gunning; J S Lacroix; P M Suter; J M Lundberg
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

2.  Circulating atrial natriuretic peptides in conscious rats: regulation of release by multiple factors.

Authors:  R Eskay; Z Zukowska-Grojec; M Haass; J R Dave; N Zamir
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

Review 3.  Endocrine changes with critical illness.

Authors:  J V Felicetta; J R Sowers
Journal:  Crit Care Clin       Date:  1987-10       Impact factor: 3.598

4.  Elevated plasma levels of endothelin in patients with sepsis syndrome.

Authors:  E Weitzberg; J M Lundberg; A Rudehill
Journal:  Circ Shock       Date:  1991-04

5.  Dose- and time-dependent changes in plasma catecholamines in response to endotoxin in conscious rats.

Authors:  S B Jones; F D Romano
Journal:  Circ Shock       Date:  1989-05

6.  Characterization of endothelin-1 stimulation of catecholamine release from adrenal chromaffin cells.

Authors:  M R Boarder; D B Marriott
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

7.  Physiologic responses to massive intraoperative hemorrhage.

Authors:  K Waxman; W C Shoemaker
Journal:  Arch Surg       Date:  1982-04

8.  Investigations of catecholamine metabolism using high-performance liquid chromatography: analytical methodology and clinical applications.

Authors:  A M Krstulović
Journal:  J Chromatogr       Date:  1982-04-16

9.  Release of vasoactive hormones and circulatory changes in shock.

Authors:  M F Wilson; D J Brackett
Journal:  Circ Shock       Date:  1983

10.  Mechanisms of impaired cardiac function by vasopressin.

Authors:  M F Wilson; D J Brackett; L T Archer; L B Hinshaw
Journal:  Ann Surg       Date:  1980-04       Impact factor: 12.969

View more
  20 in total

1.  Effect of astragalus on the endothelin in rats with acute lung injury.

Authors:  X Liu; C Huang
Journal:  J Tongji Med Univ       Date:  1999

2.  Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study.

Authors:  Robert S Hoke; Ursula Müller-Werdan; Christine Lautenschläger; Karl Werdan; Henning Ebelt
Journal:  Clin Res Cardiol       Date:  2011-11-03       Impact factor: 5.460

3.  Respiratory muscle contractile inactivity induced by mechanical ventilation in piglets leads to leaky ryanodine receptors and diaphragm weakness.

Authors:  Stefan Matecki; Boris Jung; Nathalie Saint; Valerie Scheuermann; Samir Jaber; Alain Lacampagne
Journal:  J Muscle Res Cell Motil       Date:  2017-03-04       Impact factor: 2.698

Review 4.  Biomarkers related to aging in human populations.

Authors:  Eileen Crimmins; Sarinnapha Vasunilashorn; Jung Ki Kim; Dawn Alley
Journal:  Adv Clin Chem       Date:  2008       Impact factor: 5.394

5.  Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trial.

Authors:  David B Antcliffe; Shalini Santhakumaran; Robert M L Orme; Josie K Ward; Farah Al-Beidh; Kieran O'Dea; Gavin D Perkins; Mervyn Singer; Daniel F McAuley; Alexina J Mason; Mary Cross; Deborah Ashby; Anthony C Gordon
Journal:  Intensive Care Med       Date:  2019-08-19       Impact factor: 17.440

Review 6.  A global perspective on vasoactive agents in shock.

Authors:  Djillali Annane; Lamia Ouanes-Besbes; Daniel de Backer; Bin DU; Anthony C Gordon; Glenn Hernández; Keith M Olsen; Tiffany M Osborn; Sandra Peake; James A Russell; Sergio Zanotti Cavazzoni
Journal:  Intensive Care Med       Date:  2018-06-04       Impact factor: 17.440

Review 7.  Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum.

Authors:  Davide Tommaso Andreis; Mervyn Singer
Journal:  Intensive Care Med       Date:  2016-02-12       Impact factor: 17.440

Review 8.  Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?

Authors:  Konstantinos Drosatos; Anastasios Lymperopoulos; Peter Johannes Kennel; Nina Pollak; P Christian Schulze; Ira J Goldberg
Journal:  Curr Heart Fail Rep       Date:  2015-04

9.  Leaky ryanodine receptors contribute to diaphragmatic weakness during mechanical ventilation.

Authors:  Stefan Matecki; Haikel Dridi; Boris Jung; Nathalie Saint; Steven R Reiken; Valérie Scheuermann; Ségolène Mrozek; Gaetano Santulli; Alisa Umanskaya; Basil J Petrof; Samir Jaber; Andrew R Marks; Alain Lacampagne
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-25       Impact factor: 11.205

10.  Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial.

Authors:  Martin W Dünser; Esko Ruokonen; Ville Pettilä; Hanno Ulmer; Christian Torgersen; Christian A Schmittinger; Stephan Jakob; Jukka Takala
Journal:  Crit Care       Date:  2009-11-16       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.